New nanoparticles that enhance mRNA delivery could reduce vaccine dosage, costs, and possibly even side effects. “Our goal has been to try to make nanoparticles that can give you a safe and effective vaccine response but at a much lower dose,” Daniel Anderson says.
A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate the same immune response as mRNA delivered by standard nanoparticles, but at around 1/100 the dose.









